A regulatory challenge for natural language processing (NLP)-based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?

Baumgartner, Christian; Baumgartner, Daniela

Baumgartner, Christian; Baumgartner, Daniela.

Afiliación

Baumgartner C; Institute of Health Care Engineering with European Testing Center of Medical Devices, Graz University of Technology, Graz, Austria.
Baumgartner D; Clinical Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.

Clin Transl Med ; 13(8): e1362, 2023 08.

Article en En | MEDLINE | ID: mdl-37548259

Asunto(s)

Inteligencia Artificial; Toma de Decisiones Clínicas; Procesamiento de Lenguaje Natural

Palabras clave

ChatGPT; artificial intelligence; healthcare decisions; natural language processing (NLP); regulatory approval; software as medical device (SaMD)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Procesamiento de Lenguaje Natural / Inteligencia Artificial / Toma de Decisiones Clínicas Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Transl Med Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google